| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.1M | — | -9.1% |
| Cost of Revenue | $5.9M | — | -4.3% |
| Gross Profit | $2.2M | — | -20.1% |
| R&D Expense | $32K | — | -85.3% |
| SG&A Expense | $3.6M | — | -11.2% |
| Operating Income | -$1.4M | — | -7.7% |
| Pre-tax Income | -$1.2M | — | -2.0% |
| Income Tax | $0 | — | +100.0% |
| Net Income | -$1.2M | — | -5.4% |
| EPS (Basic) | -$0.25 | — | +43.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $4.0M | +15.9% | +16.4% |
| Inventory | $13.2M | -2.3% | +11.1% |
| Current Assets | $24.8M | -7.7% | +1.2% |
| Total Assets | $27.9M | -7.1% | -4.3% |
| Current Liabilities | $5.9M | -8.8% | +2.0% |
| Total Liabilities | $6.4M | -8.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.1M | — | -20.9% |
| Capital Expenditures | $5K | — | -31.5% |
| Investing Cash Flow | -$105K | — | +40.6% |
| Financing Cash Flow | $0 | — | -100.0% |
| Free Cash Flow | -$2.1M | — | -20.7% |
| -1.1% |
| Stockholders' Equity | $21.5M | -6.6% | -5.2% |